Are All Incretin Therapies Alike? Maximizing Treatment Potential
for Patients With T2D
Are All Incretin Therapies Alike? Maximizing Treatment Potential
for Patients With T2D
Program Goals
Patient Case
How to Individualize Glycemic Targets
ADA/EASD 2012 Recommendations for Antihyperglycemic Therapy
2013 AACE Glycemic Control Algorithm
Exenatide Twice Daily vs Basal Insulin Hypoglycemia
GLP-1 RAsEffects on Blood Pressure and Lipids
DPP-4 Inhibitors as Add-on Therapy to Basal Insulin (With or
Without Oral Agents)
GLP-1 RAs vs DPP-4 Inhibitors Changes in HbA1c
GLP-1 RAs vs DPP-4 InhibitorsChanges in FPG
